Hyperglycaemia, oxidative stress and inflammatory markers

References

• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–820. doi: 10.1038/414813a
   PubMed Web of Science ®Google Scholar
• Collier B, Dossett LA, May AK, Diaz JJ. Glucose control and the inflammatory response. Nutr Clin Pract. 2008;23(1):3–15. doi: 10.1177/011542650802300103
   PubMed Web of Science ®Google Scholar
• Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res. 2003;93(12):1159–1169. doi: 10.1161/01.RES.0000103862.26506.3D
   PubMed Web of Science ®Google Scholar
• Haffner SM. Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pr. 2003;61(Suppl 1):S9–S18. doi: 10.1016/S0168-8227(03)00122-0
   PubMed Web of Science ®Google Scholar
• Gholap NN, Davies MJ, Mostafa SA, Khunti K. Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria. Br J Gen Pract. 2013;63(607):165–167. doi: 10.3399/bjgp13X663244
   Web of Science ®Google Scholar
• Federation ID. Global guidelines for type 2 diabetes. Brussels: International Diabetes Federation; 2012.
   Google Scholar
• Al-Aubaidy HA, Jelinek HF. 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort. Redox Rep. 2010;15(4):155–160. doi: 10.1179/174329210X12650506623681
   PubMed Web of Science ®Google Scholar
• Tatsch E, Bochi GV, Piva SJ, et al. Association between DNA strand breakage and oxidative, inflammatory and endothelial biomarkers in type 2 diabetes. Mutat Res. 2012;732(1–2):16–20. doi: 10.1016/j.mrfmmm.2012.01.004
   PubMed Web of Science ®Google Scholar
• Bandeira SDM, da Fonseca LJS, Guedes GdS, Rabelo LA, Goulart MOF, Vasconcelos SML. Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci. 2013;14(2):3265–3284. doi: 10.3390/ijms14023265
   PubMed Web of Science ®Google Scholar
• Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol. 2011;164(6):899–904. doi: 10.1530/EJE-11-0053
   PubMed Web of Science ®Google Scholar
• Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci. 2008;65(2):71–74. doi: 10.1080/09674845.2008.11732800
   PubMed Web of Science ®Google Scholar
• Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009;390(3):191–214. doi: 10.1515/BC.2009.033
   PubMed Web of Science ®Google Scholar
• Wu G, Fang Y-Z, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004;134(3):489–492.
   PubMed Web of Science ®Google Scholar
• Jelinek HF, Al-Aubaidy HA, Maschirow L, Meidinger S, Jamil DA, Butkowski E. Glutathione: Glutathione sulfide redox imbalance in early impaired fasting glucose. Cardiol Angiol. 2014;2(4):223–229. doi: 10.9734/CA/2014/11389
   Google Scholar
• Bannai S, Tateishi N. Role of membrane transport in metabolism and function of glutathione in mammals. J Membr Biol. 1986;89(1):1–8. doi: 10.1007/BF01870891
   PubMed Web of Science ®Google Scholar
• Toroser D, Sohal RS. Age-associated perturbations in glutathione synthesis in mouse liver. Biochem J. 2007;405(Pt 3):583–589. doi: 10.1042/BJ20061868
   PubMed Web of Science ®Google Scholar
• Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C. 2009;27(2):120–139. doi: 10.1080/10590500902885684
   Web of Science ®Google Scholar
• Maschirow L, Khalaf K, Al-Aubaidy HA, Jelinek HF. Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes – Biomarkers as a possible tool for early disease detection for rural screening. Clin Biochem. 2015;48(9):581–585. doi: 10.1016/j.clinbiochem.2015.02.015
   PubMed Web of Science ®Google Scholar
• de Carvalho VF, Guedes CP, Goncalves PL, de Cassia Goncalves AR. The role of hyperglycemia in the induction of oxidative stress and inflammatory process. Nutricion hospitalaria. 2012;27(5):1391–1398.
   PubMed Web of Science ®Google Scholar
• Lin Y, Berg AH, Iyengar P, et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem. 2005;280(6):4617–4626. doi: 10.1074/jbc.M411863200
   PubMed Web of Science ®Google Scholar
• Black PH. The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun. 2003;17(5):350–364. doi: 10.1016/S0889-1591(03)00048-5
   PubMed Web of Science ®Google Scholar
• Dallmeier D, Larson MG, Vasan RS, et al. Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study. Diabetol Met Syn. 2012;4:28. doi: 10.1186/1758-5996-4-28
   PubMed Web of Science ®Google Scholar
• Schöttker B, Herder C, Rothenbacher D, et al. Proinflammatory cytokines, adiponectin, and increased risk of primary cardiovascular events in diabetic patients with or without renal dysfunction: results from the ESTHER study. Diabetes Care. 2013;36(6):1703–1711. doi: 10.2337/dc12-1416
   PubMed Web of Science ®Google Scholar
• Salazar J, Martinez MS, Chavez M, et al. C-reactive protein: clinical and epidemiological perspectives. Cardiol Res Prac. 2014;2014:10.
   Google Scholar
• Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99(2):237–242. doi: 10.1161/01.CIR.99.2.237
   PubMed Web of Science ®Google Scholar
• Herder C, Karakas M, Koenig W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther. 2011;90(1):52–66. doi: 10.1038/clpt.2011.93
   PubMed Web of Science ®Google Scholar
• Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis. 2004;14(5):228–232. doi: 10.1016/S0939-4753(04)80048-6
   PubMed Web of Science ®Google Scholar
• Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes. 2005;54(Suppl 2):S114–S124. doi: 10.2337/diabetes.54.suppl_2.S114
   PubMed Web of Science ®Google Scholar
• Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. 2001;88(8A):10–15. doi: 10.1016/S0002-9149(01)01924-5
   PubMed Web of Science ®Google Scholar
• de Rekeneire N, Peila R, Ding J, et al. Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care. 2006;29(8):1902–1908. doi: 10.2337/dc05-2327
   PubMed Web of Science ®Google Scholar
• Schmidt FM, Weschenfelder J, Sander C, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PloS one. 2015;10(3):e0121971. doi: 10.1371/journal.pone.0121971
   PubMed Web of Science ®Google Scholar
• Spranger J, Kroke A, Möhlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetes. 2003;52(3):812–817. doi: 10.2337/diabetes.52.3.812
   PubMed Web of Science ®Google Scholar
• Butkowski EG, Brix LM, Al-Aubaidy HA, Kiat H, Jelinek HJ. Diabetes, oxidative stress and cardiovascular risk. J Med Clin Sci. 2016;5(1):17–23.
   Google Scholar
• Calabrese V, Cornelius C, Leso V, et al. Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim Biophys Acta. 2012;1822(5):729–736. doi: 10.1016/j.bbadis.2011.12.003
   PubMed Web of Science ®Google Scholar
• Dinarello CA, Donath MY, Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes. Curr Opin Endocrin Diab Obes. 2010;17(4):314–321.
   PubMed Web of Science ®Google Scholar
• van Exel E, Gussekloo J, de Craen AJM, Frölich M, Bootsma-van der Wiel A, Westendorp RGJ. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-plus study. Diabetes. 2002;51(4):1088–1092. doi: 10.2337/diabetes.51.4.1088
   PubMed Web of Science ®Google Scholar
• Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. BioMed Res Int. 2014;2014:11. doi: 10.1155/2014/406960
   Web of Science ®Google Scholar
• Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther. 2012;30(1):49–59. doi: 10.1111/j.1755-5922.2010.00218.x
   PubMed Web of Science ®Google Scholar
• Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care. 2010;33(3):562–568. doi: 10.2337/dc09-1524
   PubMed Web of Science ®Google Scholar
• Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscl Throm Vasc. 2004;24(5):816–823. doi: 10.1161/01.ATV.0000122852.22604.78
   PubMed Web of Science ®Google Scholar
• Lowe GD. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol. 2006;133(3):232–250. doi: 10.1111/j.1365-2141.2006.06021.x
   PubMed Web of Science ®Google Scholar
• Nwose EU, Richards RS, Kerr PG, Tinley R, Jelinek HF. Oxidative damage indices for the assessment of subclinical diabetic macrovascular complications. Br J Biomed Sci. 2008;65(3):136–141. doi: 10.1080/09674845.2008.11732817
   PubMed Web of Science ®Google Scholar
• Sekhar RV, McKay SV, Patel SG, et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care. 2011;34(1):162–167. doi: 10.2337/dc10-1006
   PubMed Web of Science ®Google Scholar
• Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage: antioxidant response in postprandial hyperglycaemia in type 2 diabetes mellitus. Br J Diab Vasc Dis. 2011;11(2):87–91. doi: 10.1177/1474651411405259
   Google Scholar
• Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339(1–2):1–9. doi: 10.1016/j.cccn.2003.09.010
   PubMed Web of Science ®Google Scholar
• Choi S-W, Benzie IFF, Ma S-W, Strain JJ, Hannigan BM. Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radical Biol Med. 2008;44(7):1217–1231. doi: 10.1016/j.freeradbiomed.2007.12.005
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Nanri A, Hori A, et al. Lower serum levels of total cholesterol are associated with higher urinary levels of 8-hydroxydeoxyguanosine. Nutr Metab. 2013;10(1):1–5. doi: 10.1186/1743-7075-10-59
   Google Scholar
• Miyamoto M, Kotani K, Ishibashi S, Taniguchi N. The relationship between urinary 8-hydroxydeoxyguanosine and metabolic risk factors in asymptomatic subjects. Med Princ Pract. 2011;20(2):187–190. doi: 10.1159/000319774
   PubMed Web of Science ®Google Scholar
• Subash P, Gurumurthy P, Sarasabharathi A, Cherian KM. Urinary 8-OHdG: a marker of oxidative stress to DNA and total antioxidant status in essential hypertension with South Indian population. Ind J Clin Biochem. 2010;25(2):127–132. doi: 10.1007/s12291-010-0024-z
   PubMedGoogle Scholar
• Koenen TB, Stienstra R, van Tits LJ, et al. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1β transcription in human adipose tissue. Diabetes. 2011;60(2):517–524. doi: 10.2337/db10-0266
   PubMed Web of Science ®Google Scholar
• Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53(8):2079–2086. doi: 10.2337/diabetes.53.8.2079
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117(14):3720–3732. doi: 10.1182/blood-2010-07-273417
   PubMed Web of Science ®Google Scholar
• Osborn O, Brownell SE, Sanchez-Alavez M, Salomon D, Gram H, Bartfai T. Treatment with an interleukin 1 beta antibody improves glycemic control in diet induced obesity. Cytokine. 2008;44(1):141–148. doi: 10.1016/j.cyto.2008.07.004
   PubMed Web of Science ®Google Scholar
• Fishel MA, Watson G, Montine TJ, et al. Hyperinsulinemia provokes synchronous increases in central inflammation and β-amyloid in normal adults. Arch Neurol. 2005;62(10):1539–1544. doi: 10.1001/archneur.62.10.noc50112
   PubMedGoogle Scholar
• Morohoshi M, Fujisawa K, Uchimuraa I, Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes. 1996;45(7):954–959. doi: 10.2337/diab.45.7.954
   PubMed Web of Science ®Google Scholar
• Straczkowski M, Kowalska I, Nikolajuk A, Krukowska A, Gorska M. Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals. Diabetes Care. 2005;28(8):2036–2037. doi: 10.2337/diacare.28.8.2036
   PubMed Web of Science ®Google Scholar
• Esposito K, Pontillo A, Giugliano F, et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endo Metab. 2003;88(3):1055–1058. doi: 10.1210/jc.2002-021437
   PubMed Web of Science ®Google Scholar
• Averna M, Lo Verde A. Statins and metabolic syndrome. ICS. 2003;1253:243–246.
   Google Scholar
• Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med. 1999;27(7):1262–1264. doi: 10.1097/00003246-199907000-00005
   PubMed Web of Science ®Google Scholar
• Sander M, Irwin M, Sinha P, Naumann E, Kox W, Spies C. Suppression of interleukin-6 to interleukin-10 ratio in chronic alcoholics: association with postoperative infections. Inten Care Med. 2002;28(3):285–292. doi: 10.1007/s00134-001-1199-9
   PubMed Web of Science ®Google Scholar
• Donath Marc Y, Dalmas É, Sauter Nadine S, Böni-Schnetzler M. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab. 2013;17(6):860–872. doi: 10.1016/j.cmet.2013.05.001
   PubMed Web of Science ®Google Scholar
• Xia W, Wei BAO, Jun LIU, et al. Inflammatory markers and risk of type 2 diabetes. Diabetes Care. 2013;36(1):166–175. doi: 10.2337/dc12-0702
   PubMed Web of Science ®Google Scholar
• Biswas S, Ghoshal PK, Mandal SC, Mandal N. Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction. Korean J Intern Med. 2010;25(1):44–50. doi: 10.3904/kjim.2010.25.1.44
   PubMedGoogle Scholar
• Weis F, Beiras-Fernandez A, Schelling G, et al. Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: effects on interleukin-6 to interleukin-10 ratio and early outcome. Crit Care Med. 2009;37(5):1685–1690. doi: 10.1097/CCM.0b013e31819fca77
   PubMed Web of Science ®Google Scholar
• Chang JS, Chang CC, Chien E, et al. Association between interleukin 1beta and interleukin 10 concentrations: a cross-sectional study in young adolescents in Taiwan. BMC Pediatr. 2013;13:313. doi: 10.1186/1471-2431-13-123
   Web of Science ®Google Scholar
• Zhao G, Dharmadhikari G, Maedler K, Meyer-Hermann M. Possible role of interleukin-1beta in type 2 diabetes onset and implications for anti-inflammatory therapy strategies. PLoS Comput Biol. 2014;10(8):e1003798. doi: 10.1371/journal.pcbi.1003798
   PubMed Web of Science ®Google Scholar